Highbridge Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-103,300
| Closed | -$9.61M | – | 801 |
|
|
2017
Q3 | $9.61M | Buy |
103,300
+43,300
| +72% | +$4.03M | 0.14% | 140 |
|
|
2017
Q2 | $5.45M | Sell |
60,000
-5,870
| -9% | -$533K | 0.08% | 216 |
|
|
2017
Q1 | $5.78M | Sell |
65,870
-52,473
| -44% | -$4.61M | 0.08% | 231 |
|
|
2016
Q4 | $9.8M | Buy |
118,343
+1,643
| +1% | +$136K | 0.17% | 139 |
|
|
2016
Q3 | $10.8M | Buy |
116,700
+79,400
| +213% | +$7.35M | 0.17% | 125 |
|
|
2016
Q2 | $2.9M | Buy |
+37,300
| New | +$2.9M | 0.05% | 306 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 828 |
|
|
2015
Q4 | – | Sell |
-20,478
| Closed | -$2.16M | – | 840 |
|
|
2015
Q3 | $2.16M | Sell |
20,478
-11,596
| -36% | -$1.22M | 0.03% | 390 |
|
|
2015
Q2 | $4.39M | Buy |
32,074
+13,661
| +74% | +$1.87M | 0.06% | 287 |
|
|
2015
Q1 | $2.29M | Buy |
+18,413
| New | +$2.29M | 0.03% | 381 |
|
|
2013
Q4 | – | Sell |
-19,333
| Closed | -$1.4M | – | 710 |
|
|
2013
Q3 | $1.4M | Sell |
19,333
-50,412
| -72% | -$3.64M | 0.01% | 508 |
|
|
2013
Q2 | $3.89M | Buy |
+69,745
| New | +$3.89M | 0.04% | 342 |
|